Overview
c-LEcta is a Germany-based biotechnology company founded in 2004, specializing in enzyme engineering and industrial bioprocess development for regulated markets such as pharmaceuticals and food production. The company develops and manufactures customized enzymes and microbial production strains, enabling efficient and sustainable production processes across multiple industries. A key strength of c-LEcta is its proprietary ENESYZ® technology platform, which enables rapid discovery, optimization, and large-scale production of enzymes tailored to specific industrial applications. Since 2022, c-LEcta has been part of the Kerry Group, a global leader in food, nutrition, and biotechnology solutions, further strengthening its global reach and production capabilities. The company serves over 400 customers across 40+ countries, providing solutions for biopharmaceutical manufacturing, food production, and sustainable industrial processes.
Key techniques
c-LEcta supports advanced industrial biotechnology and enzyme engineering workflows
Product lines
c-LEcta offers a focused portfolio of industrial enzyme solutions and bioprocess services
Capabilities
c-LEcta integrates enzyme engineering, bioprocess development, and industrial-scale production
QC & documentation
c-LEcta provides extensive regulatory and technical documentation
Lead time & shipping
Timelines depend on product scale and customization.